SCHEMBL3657976

SCHEMBL3657976

CCOC(=O)CN(Cc1ccc(OC)cc1OC)Cc1c(-c2ccncc2)noc1C(=O)OCC.CCOC(=O)c1ncc2c(-c3ccncc3)noc2c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.39
MAPT P10636 3/20 0.35
GABRA1 P14867 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA3 P34903 2/20 0.33
GABRA2 P47869 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33
GABRG1 Q8N1C3 1/20 0.33
GABRG3 Q99928 1/20 0.33
GABRQ Q9UN88 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3660421 0.95 MAPT (0.36) POLBMAPTGABRA1GABRG2GABRB3
SCHEMBL3663330 0.94 PTPN1 (0.38) POLBMAPTGABRA5MEN1KMT2A
SCHEMBL3660444 0.93 TP53 (0.35) POLBMAPTGABRA1GABRG2GABRB3
SCHEMBL2776138 0.90 POLB (0.47) POLBMAPTMEN1KMT2ACDC7
SCHEMBL3660246 0.87 MEN1 (0.35) POLBMAPTGABRA1GABRG2GABRB3
SCHEMBL2779106 0.85 POLB (0.41) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL2777556 0.83 PTPN1 (0.43) POLBMAPTGABRA5MEN1KMT2A
SCHEMBL2777595 0.82 TP53 (0.39) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL3663664 0.81 PTPN1 (0.41) POLBMAPTGABRA5MEN1KMT2A
SCHEMBL2776688 0.78 MEN1 (0.42) POLBMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2227475-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS Fibrogen, Inc. (US) 2010-09-15 EP disclosed
WO-2009073669-A1 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS FIBROGEN, INC. (US) 2009-06-11 WO disclosed